NSETrading Window25 Jun 2026 · 25 Jun 2026, 07:57 pm
Trading Window
Sun Pharmaceutical Industries Limited · SUNPHARMA
✦ AI Summary
Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
SUNSEC_25062026195412_SEintimationforCTW.pdf
View document text
Sun Pharmaceutical Industries Limited
SUN HOUSE, Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai 400063, India
Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343
Website: www.sunpharma.com
Email: secretarial@sunpharma.com
CIN: L24230GJ1993PLC019050
25 June 2026
National Stock Exchange of India Limited BSE Limited
Scrip Symbol: SUNPHARMA Scrip Code: 524715
Trading Window Closure
Pursuant to the Company’s Code of Conduct for Prohibition of Insider Trading, the Trading Window for
dealing in Company’s shares shall remain closed during the period starting from 01 July 2026, till 48 hours
after the declaration of Unaudited Financial Results for the quarter ended 30 June 2026.
The date of the Board Meeting to consider and approve the Unaudited Financial Results for the quarter ended
30 June 2026 shall be communicated in due course.
For Sun Pharmaceutical Industries Limited
(Anoop Deshpande)
Company Secretary and Compliance Officer
ICSI Membership No.: A23983
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA
Reaching People. Touching Lives